Antibody characterization is a critical process in the development of veterinary biologics, involving a suite of analytical methods to determine the biochemical and biophysical properties of an antibody. This comprehensive analysis confirms the identity, purity, and stability of a therapeutic candidate, which is fundamental for regulatory submissions and ensuring product safety and efficacy. As highlighted in recent scientific literature, a multi-faceted approach to characterization, from primary sequence verification to functional and stability assessments, is essential for mitigating risks in later-stage development and manufacturing.
Comments